Vous êtes ici

Pharmadrug Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
PHRX
Indice CSE: 
Devise: 

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. PharmaDrug owns 100% of Pharmadrug Production GmbH (“Pharmadrug Production”), a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the European Union. PharmaDrug owns 100% Sairiyo Therapeutics (“Sairiyo”), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also owns 100% of Super Smart, a company building a vertically integrated retail business with the goal to elevate the use of functional mushrooms as natural based medicines.

Vous êtes ici

Pharmadrug Inc. (PHRX)

SEDAR Information

Information d'entreprise

Addresse
77 King St. West, Suite 2905
Toronto, ON M5K 1H1
Canada
Téléphone
647-202-1824
Fax
416-765-0029
Courriel
info@aurahealthinc.com
URL
http://www.pharmadrug.com
Date d’inscription à la cote
Jeudi, août 16, 2018
Agent de transfert
Capital Transfer Agency

Advertisement

Publicité

Capitalisation

Capitalisation: 
355,626,346
Réservé à l'émission: 
75,502,328

Company Officers

Daniel Cohen, CFA, CEO
Keith Li, CPA, CFO

Bulletins

17/05/2023

2023-0527 - Réintégration – Pharmadrug Inc. (PHRX)

le 17 mai/May 2023

Effective immediately, Pharmadrug Inc. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

Advertisement

Publicité

Latest CSE News

Évènements à venir

TAKESTOCK - Calgary Investor Forum

TAKESTOCK - Calgary Investor Forum

Mercredi, juin 7, 2023 -
09:00 - 17:00
Summit on Responsible Investment

Summit on Responsible Investment

Mardi, juin 27, 2023 -
09:00 - 19:00